子宮內膜異位癥sICAM

子宮內膜異位癥sICAM

【關鍵詞】 子宮內膜異位癥
Changes of sICAM1 and sHLAⅠin endometriosis and its significance
　　【Abstract】 AIM: To investigate the relationship between endometriosis (EMs) and the levels of soluble intercellular adhesion molecule1 (sICAM1) and soluble human leucocyte antigen1 (sHLAⅠ). METHODS: Thirty serum and 30 peritoneal fluid (PF) of patients with EMs (test group) and 30 serum and 30 peritoneal fluid of patients without EMs (control group) were studied. The levels of sICAM1 and sHLAⅠwere detected by enzymelinked immunosorbent assay (ELISA). RESULTS: ① Significantly higher levels of sICAM1 in serum and PF were observed in patients with EMs compared with those in controls (P0.05). ② The levels of sICAM1 in serum and PF were significantly different and the levels in earlystage EMs group were higher than those in advanced group (P0.05). ③ Serum sHLAⅠ cevel was lower in EMs group (P0.05) but the level in earlystage EMs group was higher than that in advanced group (P0.05). ④ There were no statistically significant differences in the levels of sHLAⅠin PF between the patients and the controls (P0.05). CONCLUSION: Changes of sICAM1and sHLAⅠmay play a role in the genesis of endometriosis.
　　【Keywords】 endometriosis; HLA antigens; intercellular adhesion molecule1; enzymelinked immunosorbent assay
　　【摘要】 目的： 探討盆腔子宮內膜異位癥（內異癥）患者血清和腹腔液中可溶性細胞間粘附分子1(sICAM1)、可溶性人類白細胞抗原Ⅰ(sHLAⅠ)的水平與該病的發病關系. 方法： 以ELISA法定量檢測sICAM1的水平、半定量檢測sHLAⅠ水平. 結果： 內異癥組血清和腹腔液中sICAM1和sHLAⅠ水平明顯高于對照組(P

【子宮內膜異位癥sICAM】相關文章：

核因子κB在子宮內膜異位癥中的表達和意義03-08

腹腔鏡下子宮肌瘤剔除術與開腹子宮肌瘤剔除術的比較03-16

166例子宮肌瘤臨床分析03-16

頸動脈內膜—中層厚度的超聲評價與冠心病相關性研究03-29

腹腔鏡輔助陰式子宮切除術03-18

反義CD151基因抑制血管損傷后內膜增生的實驗研究03-08

陰式子宮切除術在婦產科的臨床效果論文11-13

探討臨床護理路徑在子宮全切術中的應用效果03-07